Jean Delwaide
AuthID: R-00F-GSC
1
TITLE: HCVerso2: A phase III study of faldaprevir (FDV) plus deleobuvir (DBV) and ribavirin (RBV) for chronic HCV genotype (GT)-1b infection in treatment-naive patients including those ineligible for pegylated interferon (PegIFN)
AUTHORS: David R Nelson; Pietro Andreone; Massimo Colombo; Filipe Calinas; Antonio Olveira; Jean Delwaide; Dieter Haeussinger; Denis Ouzan; Simone I Strasser; Tarik Asselah; Curtis Cooper; Jerry O Stern; Wulf O Boecher; George Kukolj; Stella Aslanyan; Qiqi Q Deng; Edward Wang; Federico J Mensa;
PUBLISHED: 2014, SOURCE: 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases in HEPATOLOGY, VOLUME: 60
AUTHORS: David R Nelson; Pietro Andreone; Massimo Colombo; Filipe Calinas; Antonio Olveira; Jean Delwaide; Dieter Haeussinger; Denis Ouzan; Simone I Strasser; Tarik Asselah; Curtis Cooper; Jerry O Stern; Wulf O Boecher; George Kukolj; Stella Aslanyan; Qiqi Q Deng; Edward Wang; Federico J Mensa;
PUBLISHED: 2014, SOURCE: 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases in HEPATOLOGY, VOLUME: 60
INDEXED IN: 
WOS
WOS